Amitava Banerjee is NIHR Clinical Lecturer in Cardiovascular Medicine and Honorary Specialist Registrar in Cardiology.
Ami has over 30 scientific publications, including review articles and book chapters, in the fields of epidemiology, cardiology and global health. His epidemiology work has largely focused on the sex-specific effects of family history of myocardial infarction and stroke on risk of future cardiovascular disease. His major global health interests are access to medicines and the burden of cardiovascular disease in India.
He spends his time between clinical cardiology, research and teaching, and is now based in Professor Gregory Lip’s research group in the Centre for Cardiovascular Sciences.
2011 DPhil (Oxon)
2007 MRCP (London)
2005 MPH (Harvard)
2002 MBBCh (Oxon)
1999 MA Hons (Oxon)
Amitava Banerjee qualified MBBCh from Oxford Medical School in 2002, where he was awarded the Radcliffe Prize for contribution to clinical school life. He trained as a junior doctor in Oxford, Newcastle, Hull and London, and took up his Clinical Lecturer post in Cardiology in Birmingham in March 2011. His interest in preventive cardiology led him to complete a Masters in Public Health at Harvard University in 2004/05, funded by a Frank Knox Memorial Fellowship. Epidemiology and evidence-based medicine were the obvious ways to marry his passions for cardiology and public health. He first worked with the Cardiovascular Diseases Division at the World Health Organisation as an intern in 2005, but has continued to work there as a WHO Temporary Advisor.
In 2011, he completed his DPhil in cardiovascular epidemiology in the Stroke Prevention Research Unit in Oxford, focusing on acute coronary syndromes under the supervision of Professor Peter Rothwell. During his DPhil, he held a Graduate Scholarship in Sciences at St Catherine’s College, University of Oxford. He has presented his research work at several national and international meetings, receiving a Young Investigator Award at the European Stroke Conference in 2008 and an Early Career Travel Award from the American Heart Association in 2009.
Medical education has always been a keen interest, and Ami was previously Tutor for Clinical Studies at Lady Margaret Hall, University of Oxford (2006-2010). He continues to regularly teach undergraduate and postgraduate students. Outside of clinical practice, his interests include global health, improving access to medicines and medical education.
In addition, public engagement in science has developed as an important area of his work. Ami co-writes the popular evidence-based healthcare blog, trusttheevidence.net, which aims to 'unpack' the data and statistics in news stories about health and health research.
MB ChB course – 1st year cardiology module, and clinical teaching of 3rd and 5th year MB students
BMedSci International Health-lectures on non-communicable disease
Ami will be starting supervision of graduate students this year.
Current epidemiology research interests are atrial fibrillation and novel anticoagulant therapies for atrial fibrillation. In terms of global health, access to medicines is his main interest as well as the global burden of cardiovascular disease. His doctoral research included comparative epidemiology of cerebrovascular, coronary and peripheral vascular disease and family history of cardiovascular disease.
Honorary specialist registrar in Cardiology, City Hospital, Birmingham
Member of BMA Medical Academic Staff Committee (MASC)
Medical Advisor, Incentives for Global Health
Advanced Life Support Instructor
Teaching faculty at Centre for Evidence Based Medicine, University of Oxford
Co-editor of trusttheevidence.net (http://trusttheevidence.net), an evidence-based blog
Senior Associate at Diagnosis, a non-profit healthcare consultancy which specialises in gaining consultancy work for junior doctors in training in the NHS
Banerjee A, Lip GY. Intracerebral hemorrhage and warfarin: perceived versus actual risk. Stroke. 201;42:2383-4.
Bhala N, Taggar JS, Rajasekhar P, Banerjee A. Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment. BMJ. 2011 Jul 21;343:d4264.
Banerjee A, Silver LE, Heneghan C, Welch SJ, Mehta Z, Banning AP, Rothwell PM. Relative familial clustering of cerebral versus coronary ischemic events. Circulation Cardiovascular Genetics. 2011;4:390-6.
Banerjee A, Lim CCS, Silver LE, Welch SJV, Banning AP, Rothwell PM. Familial history of stroke is associated with acute coronary syndromes in women. Circulation Cardiovascular Genetics. 2011.4:9-15
Banerjee A, Fowkes FG, Rothwell PM. Associations between peripheral artery disease and ischaemic stroke: implications for primary and secondary prevention. Stroke. 2010.41:2102-7.
Banerjee A, Hollis A and Pogge T. The Health Impact Fund: incentives for improving access to medicines. Lancet. 2010. 375:166-169.
Banerjee A, Silver LE, Heneghan C, Welch SJV, Bull LM, Mehta Z, Banning AP, Rothwell PM. Sex-specific familial clustering of myocardial infarction in patients with acute coronary syndromes in the heritability of myocardial infarction. Circulation Cardiovascular Genetics. 2009. 2:98-105.
Mendis S, Banerjee A (2010). “Cardiovascular disease: equity and social determinants”; in Blas E. and Kurup AS (eds) Equity, social determinants and public health programmes. World Health Organization, pp.31-48.